Letrozol i fertilitetsbehandling

Emilie Steentoft Dahlberg*, Dorte Andersen, Pernilla Skjødt Andersson, Kathrine Birch, Lotte Colmon, Marianne Dreyer Holt, Kasper Ingerslev, Kirstine Kirkegaard, Kristine Løssl, Liv la Cour Poulsen, Marie-Louise Wissing, Mathilde Yde, Nathalie Søderhamn Bülow

*Corresponding author af dette arbejde

Abstract

This review describes the current evidence regarding the putative indications of letrozole (LTZ) in fertility treatment. Prior to intrauterine insemination, LTZ is recommended in women with normogonadotrophic oligo-anovulation. In ovulatory women, LTZ is equal to clomiphene and may be used instead of exogenous gonadotrophin. LTZ may be used as co-treatment in poor responders prior to in vitro fertilization/intracytoplasmic sperm injection. In addition, LTZ prior to frozen-thawed embryo transfer is increasingly used in women with normogonadotrophic oligo-anovulation.

Bidragets oversatte titelLetrozole in fertility treatment
OriginalsprogDansk
ArtikelnummerV05230315
TidsskriftUgeskrift for Laeger
Vol/bind185
Udgave nummer41
ISSN0041-5782
StatusUdgivet - 9 okt. 2023

Emneord

  • Anovulation/therapy
  • Clomiphene/therapeutic use
  • Female
  • Fertility Agents, Female
  • Humans
  • Letrozole/therapeutic use
  • Male
  • Semen

Fingeraftryk

Dyk ned i forskningsemnerne om 'Letrozol i fertilitetsbehandling'. Sammen danner de et unikt fingeraftryk.

Citationsformater